Nijmegen-based Thirona, a company that specializes in advanced analysis of thoracic CT images with artificial intelligence (AI), announced that it has secured €7.5M in a fresh round of funding.
This funding includes a €5M investment from HERAN Partners and Dutch-based Borski Fund, along with a €2.5M grant from the European Innovation Council (EIC).
Thirona BV, founded by scientist Eva van Rikxoort in 2014, is an AI company specializing in precise image analysis of retinal and lung images.
It offers expertise-based services to medtech, pharmaceutical, and CRO (Contract Research Organisation) companies in this field.
Thirona claims its technology can significantly improve the precision and efficiency of bronchoscopic and surgical lung procedures (making them easier and less invasive for patients), including robotic procedures, by analyzing medical images.
The Dutch company’s lung quantification platform, LungQ, encompasses a robust and high-performance set of AI-based algorithms.
These algorithms are trained on diverse disease-specific datasets, providing top-notch analytical capabilities in the market.
With over 15 million images analyzed, the company says it is a globally recognized expert in advanced image analysis.
LungQ is a scalable AI platform that delivers consistent and reproducible results, making it suitable for both exploratory research studies and large multi-site clinical trials.
Thirona partners with research institutions and medical companies to advance precision medicine for personalized pulmonary disease treatment.
Thirona says it will use the funds to accelerate the adoption of its “breakthrough” innovations for precision medicine.
Read more on Tech Gist Africa: